ReVerz Med SRL
ReVerz Med reported total assets of €1.07m at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Feb 2026).
By total assets for 2025, ReVerz Med ranks among the 5,000 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of ReVerz Med shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +271 % Total assets +161 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ReVerz Med's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Feb 2026
- Year ended 31 Dec 2024filed on 24 Feb 2025
- Year ended 31 Dec 2023filed on 16 Jun 2024
ReVerz Med's financial analysis
- Solvency87.1%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ReVerz Med
ReVerz Med's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0793.423.673
- VAT number
- BE0793423673
- Peppol
- Registered · 0208:0793423673 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Nov 2022
- Registered office
- 2491 Balen
- Latest accounts
- 2025 · filed on 09 Feb 2026
- Activity
- Medical specialists activities (NACE 86220)
ReVerz Med (SRL) has been based in Balen since 2022, active in: medical specialists activities. For 2025, it reports a net profit of 367,476 € and equity of 930,035 €; its revenue is not published. Its solvency stands at 87.1%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to ReVerz Med
Companies in the same business, of comparable size and area, outside its group.
- VD Consulting Business and other management consultancy activities Maldegem · balance sheet €1.07m
- Serlesco Knokke-Heist · balance sheet €1.07m
- A.P.R. Betonpomp Manufacture of basic pharmaceutical products Nijlen · balance sheet €1.07m
- Dokter J. Opheide Medical specialists activities Geel · balance sheet €1.07m
- Cibum Invest Buying and selling of own real estate Olen · balance sheet €1.07m
- Provert Immo Namur · balance sheet €1.07m
- Docteur Beatrice Fourir Limbourg · balance sheet €1.07m
- Grimmo Brussels · balance sheet €1.07m
Frequently asked questions about ReVerz Med
What is the revenue of ReVerz Med?
ReVerz Med files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ReVerz Med?
In Belgium, the VAT number is the company number prefixed with BE: BE0793423673 for ReVerz Med, if the company is VAT-registered. Its company number (CBE) is 0793.423.673.
Where is the registered office of ReVerz Med?
According to the CBE register, the registered office of ReVerz Med is in 2491 Balen.
What is the equity of ReVerz Med?
At the close of the 2025 financial year, the equity of ReVerz Med amounts to 930,035 €, a solvency of 87.1% of total assets.
Who manages ReVerz Med?
The register lists 1 active mandates at ReVerz Med. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is ReVerz Med within its sector?
By total assets for 2025, ReVerz Med ranks among the 5,000 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of ReVerz Med
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →